Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jan 5;129(1):116-7.
doi: 10.4103/0366-6999.172611.

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis

Christian J Wiedermann  1
Affiliations
Comment

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis

Christian J Wiedermann. Chin Med J (Engl). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot of all-cause mortality in relation to risk of bias in trials. The size of squares for Mantel–Haenszel (M-H) risk ratio reflects the weight of trial in pooled analyses. Horizontal bars represent 95% confidence intervals. Results of a mixed effect analysis are shown. Pooled effect size and subgroup analyses are based on a fixed effects model using Comprehensive Meta-analysis version 2.2.064.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Ma PL, Peng XX, Du B, Hu XL, Gong YC, Wang Y, et al. Sources of heterogeneity in trials reporting hydroxyethyl starch 130/0.4 or 0.42 associated excess mortality in septic patients: A systematic review and meta-regression. Chin Med J. 2015;128:2374–82. doi: 10.4103/0366-6999.163387. - PMC - PubMed
    1. Zhu GC, Quan ZY, Shao YS, Zhao JG, Zhang YT. The study of hypertonic saline and hydroxyethyl starch treating severe (in Chinese) Chin Crit Care Med. 2011;23:150–3. - PubMed
    1. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial. JAMA. 2013;310:1809–17. doi: 10.1001/jama.2013.280502. - PubMed
    1. Perner A, Haase N, Wetterslev J. Mortality in patients with hypovolemic shock treated with colloids or crystalloids. JAMA. 2014;311:1067. doi: 10.1001/jama.2014.830. - PubMed
    1. Brun-Buisson C, Sun J, Natanson C. Mortality in patients with hypovolemic shock treated with colloids or crystalloids. JAMA. 2014;311:1068–9. doi: 10.1001/jama.2014.836. - PubMed

Substances